Company news

AdAlta Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

EW-001 Orphan Drug Designation, pre-IND update

November 16, 2026

$1.4m additional RDTI refund

November 11, 2026

Letter to Shareholders, Notice of AGM & Proxy Form

October 29, 2026

Change of AGM Date

October 27, 2026

Quarterly Appendix 4C and Activities Report

October 25, 2026

RDTI receipt, Advanced Overseas Finding

October 18, 2026

RDTI receipt, Advanced Overseas Finding

October 18, 2026

EW-001 JDC milestone approvals

October 4, 2026

China Representative Office opens

September 30, 2026

Date of AGM & Closing Date for Director Nominations

September 29, 2026

US FDA grants EW-001 pre-IND meeting

September 22, 2026

Oribiotech deal validates AdAlta manufacturing strategy

September 17, 2026

CAR-TCR Summit poster

September 14, 2026

Bilingual BIOSeedin Investor Presentation

September 9, 2026

BZDS1901 special access scheme launch in China

September 1, 2026

Appendix 4G and Corporate Governance Statement

August 21, 2026

Annual Report to shareholders

August 21, 2026

Preliminary Final Report

August 21, 2026

Investor presentation

August 12, 2026

EW-001 IIT study overall survival update

August 9, 2026

2 year survival milestone for EW-001 patient

August 4, 2026

Quarterly Appendix 4C and Activities Report

July 28, 2026

Oktopi AI collaboration for research efficiency

July 1, 2026

Second BZDS1901 milestone paid

June 30, 2026

Regulatory advisors appointed for BZDS1901

May 24, 2026

$2.5m placement

May 4, 2026

BZDS1901 manufacturing agreement

April 28, 2026

Automated cell therapy manufacturing MoU

April 20, 2026

BZDS1901 clinical update

March 31, 2026

AdCella and SHcell hold first JDC meeting

March 26, 2026

New AD-214 patent granted

March 19, 2026

AdCella expands clinical advisory board

March 3, 2026

AdCella Clinical Advisory Board convened

February 25, 2026

Half Yearly Report and Accounts

February 19, 2026

Quarterly Appendix 4C and Activities Report

January 29, 2026

AdCella milestones and regulatory progress

January 20, 2026

Placement raises A$1.2 million

January 12, 2026

CAR-T collaboration agreement

January 1, 2026

$0.78 million FY25 RDTI refund received

December 3, 2025

AGM share consolidation resolution withdrawal

November 6, 2025

Meurs Group Investment Agreement Update

October 27, 2025

NLSC investment balance repaid

October 23, 2025

Letter to Shareholders, Notice of AGM & Proxy Form

October 23, 2025

At market Placement raises additional up to A$1.1 million

October 19, 2025

Placement raises up to A$0.5 million and transaction update

October 12, 2025

Preliminary Final Report

August 26, 2025

Investor Presentation - TechKnow Invest Roadshow

August 18, 2025

Renounceable Rights Issue shortfall placed

June 12, 2025

Rights Issue raises $1.1million

June 2, 2025

Notice of change of exercise price of options

May 28, 2025

Older news releases →

Decks

The 5 newest of 84 decks. Every deck is listed under its year.